AA
ZSPH

AQR Arbitrage’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

AQR Arbitrage’s Portfolio ZSPH Stock Details ZSPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-75,000
Closed -$3.16M – 479
2015
Q1 		$3.16M Buy
+75,000
New +$3.43M 0.04% 206

Other funds holding ZSPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

AQR Arbitrage's ZSPH Position: Q2 2015 in Review

AQR Arbitrage sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q2 2015, closing a stake of 75,000 shares — an estimated $3.16M sold.

AQR Arbitrage first reported a position in ZSPH in Q1 2015 and held it in 1 quarter. The position peaked at $3.16M in Q1 2015. 120 funds tracked by Wall St. Rank hold ZSPH as of Q2 2015.

  • AQR Arbitrage reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q2 2015 after selling out during the quarter.
  • AQR Arbitrage sold 75,000 ZS PHARMA INC COMS TK (DE) shares in Q2 2015, an estimated $3.16M.
  • AQR Arbitrage first reported a position in ZS PHARMA INC COMS TK (DE) in Q1 2015 and held it in 1 quarter.
  • AQR Arbitrage's ZS PHARMA INC COMS TK (DE) position peaked at $3.16M in Q1 2015.
  • 120 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q2 2015.

Based on AQR Arbitrage's 13F filing for Q2 2015, filed 14 Aug 2015.